Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2025, Vol. 30 ›› Issue (7): 968-976.doi: 10.12092/j.issn.1009-2501.2025.07.012

Previous Articles     Next Articles

Research progress on non-coding RNA mediated apoptosis in lung cancer

LIU Dewei, WU Dong, HUANG Dan, ZHAO Xuanna, WU Bin   

  1. Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, Guangdong, China
  • Received:2024-11-20 Revised:2024-12-19 Online:2025-07-26 Published:2025-07-02
  • About author:刘德伟,男,硕士,研究方向:肺癌。 E-mail: 1040426101@qq.com

Abstract:

Lung cancer is the most common malignant tumors in clinical practice, posing a significant threat to human health. In recent years, with the advancement of high-throughput sequencing technologies, a large number of non-coding RNAs (ncRNAs) have been found to play crucial roles in the regulation of apoptosis in lung cancer cells. This article reviews the research progress of ncRNA (miRNA, lncRNA, circRNA, piRNA) mediated apoptosis in lung cancer, aiming to provide new theoretical basis for ncRNA therapy of lung cancer.

Key words: Lung cancer, Apoptosis, ncRNA, miRNA, lncRNA, circRNA, piRNA

CLC Number: